← Open Payments lookup

MONIQUE PHAN: Open Payments

NPI 1144005166 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,027 in 50 payments from 15 companies in 2025. Trend: 2023 $194 · 2024 $1,216 · 2025 $1,027

Food & beverage: $1,027
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.9$248
Lilly USA, LLC9$132
GlaxoSmithKline, LLC.5$97
AstraZeneca Pharmaceuticals LP5$81
Astellas Pharma US Inc3$76
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$74
Medtronic, Inc.1$64
Novo Nordisk Inc3$58
Corcept Therapeutics2$53
Boehringer Ingelheim Pharmaceuticals, Inc.2$31

Products named: GEMTESA, TRELEGY ELLIPTA, Veozah, XIFAXAN, JARDIANCE, KYPHON EXPRESS II KYPHOPAK TRAY, Korlym, BREZTRI.

Industry payments across AZ — which companies pay providers there.